Biomedical Research Infrastructure Goes Global

Six institutions from Canada, the Czech Republic, Austria, France and Italy have now become official partners of the Infrafrontier consortium. With the participation of Canada, the consortium will be extended beyond Europe. The aim is to create a multinational research infrastructure for the phenotyping and archiving of mouse models of human diseases.

Helmholtz Zentrum München today announced that the Infrafrontier project, funded by the European Union, has been expanded to include six partners from Canada, the Czech Republic, Austria, France and Italy. The new partners will join the effort of the other 22 members of Infrafrontier in building up an international research infrastructure to improve open access to high-quality mouse models. Animal models have become an important tool in the study of complex human diseases such as diabetes, osteoporosis, asthma and depression, but also in the study of fundamental mechanisms such as speech development in humans. Colin McKerlie, spokesman of the Canadian partner, views the partnership as a "crucial step to successfully face one of the most interesting scientific challenges of the 21st century; to understand the function of every gene in the genome."

Professor Martin Hrabé de Angelis is director of the Institute of Experimental Genetics at Helmholtz Zentrum München and coordinates the EU Project Infrafrontier. "The international expansion facilitates the networking of the best scientists across the globe," Martin Hrabé de Angelis said. This opportunity is especially important to the Czech partners, as Prof. Radislav Sedlacek, programme coordinator for the Czech Center for Phenogenomics, stressed.

"We know that in the coming years we will be confronted with scientific tasks that cannot be solved with the infrastructure we currently have in Europe," Hrabé de Angelis went on to say. Infrafrontier will close this gap by expanding existing facilities and building new ones. A central coordination unit shall also be established. These endeavors will provide biomedical research with an international, open-access research infrastructure.

The partners in the Infrafrontier Consortium are the leading European systemic phenotyping centers (mouse clinics), the members of EMMA (European Mouse Mutant Archive) and research ministries and major funding agencies. New to Infrafrontier are the Czech Center for Phenogenomics and the Czech Republic's Ministry for Education, Youth and Sport, the Veterinary University of Vienna, the French institute INSERM (Institut National de la Santé et de la Recherche Médicale), the Italian Ministry of Labor, Health and Social Sciences and the Toronto Center for Phenogenomics. Altogether, 12 European countries and Canada now participate in Infrafrontier.

Infrafrontier is part of the ESFRI (European Strategy Forum on Research Infrastructures) roadmap, which outlines a plan to create research infrastructures of great scientific importance and pan-European interest, and which is therefore funded by the European Union.

For further information, please visit:
http://www.infrafrontier.eu

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...